Cart
sales@molnova.com
AXC-666
CAS No. 313350-30-0
AXC-666( —— )
Catalog No. M37595 CAS No. 313350-30-0
AXC-666 is a TLR agonist and an immuno agonist that can be used to synthesize antibody drug couplers (ADCs).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | Get Quote |
|
| 5MG | 63 | Get Quote |
|
| 10MG | 103 | Get Quote |
|
| 25MG | 199 | Get Quote |
|
| 50MG | 322 | Get Quote |
|
| 100MG | 473 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAXC-666
-
NoteResearch use only, not for human use.
-
Brief DescriptionAXC-666 is a TLR agonist and an immuno agonist that can be used to synthesize antibody drug couplers (ADCs).
-
DescriptionAXC-666, an immune agonist, is a Imiquimod (HY-B0180) derivative. AXC-666 can be used for the synthesis of antibody-drug conjugate (ADC).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayAntibody Drug Conjugates (ADC)
-
TargetADC Cytotoxin
-
RecptorADC Cytotoxin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number313350-30-0
-
Formula Weight283.37
-
Molecular FormulaC16H21N5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESN1=C(N)C=2N=C(N(C2C=3C=CC=CC13)CCCCN)CC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Moon SJ, et, al. Compositions containing, methods and uses of antibody-tlr agonist conjugates. WO2020168017.
molnova catalog
related products
-
SG3199
SG3199 (SG-3199) is a PBD dimer warhead component of antibody-drug conjugate (ADC) payload tesirine, demonstrates potently cytotoxic against a panel of human solid tumour and haematological cancer cell lines with mean GI50 of 151.5 pM.
-
MMAD hydrochloride
A potent tubulin inhibitor that is a toxin payload in antibody drug conjugates (ADCs).
-
Calicheamicin
Calicheamicin γ1 is an enediyne antitumor antibiotic that acts by binding to DNA and causes strand scission; ADC payload used in development of antibody drug conjugates.
